Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
SAVVY Vaginal Gel
Product Overview
Alternative Name:
C31G Vaginal Gel
Development Status:
Inactive
Target:
Female
Mode:
Non-hormonal
Delivery Type:
Vaginal Gel
Duration Type:
Short-acting
Description:
C31G Vaginal Gel (1%) has components myristamine oxide and cetyle betaine.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
myristamine oxide
,
cetyl betaine
Potential Multi-Purpose Technology (MPT):
Yes
Partner:
Adamis Pharmaceuticals
Status
Project Phase:
Late Development
Project Stage:
Phase III
Programmatic Considerations
Considerations:
Product is as effective as nonoxynol-9 in preventing pregnancy without causing vaginal irritation.
Product is woman controlled.
Product has not been demonstrated to have a protective effect on HIV transmission compared with the vehicle, however, product usage was not consistent in the HIV studies.
Additional Information
Download Product Report
